Your browser doesn't support javascript.
loading
Yaws re-emergence and bacterial drug resistance selection after mass administration of azithromycin: a genomic epidemiology investigation.
Beale, Mathew A; Noguera-Julian, Marc; Godornes, Charmie; Casadellà, Maria; González-Beiras, Camila; Parera, Mariona; Kapa Jnr, August; Houinei, Wendy; Wangi, James; Corbacho-Monne, Marc; Paredes, Roger; Gonzalez-Candelas, Fernando; Marks, Michael; Lukehart, Sheila A; Thomson, Nicholas R; Mitjà, Oriol.
  • Beale MA; Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK. Electronic address: mathew.beale@sanger.ac.uk.
  • Noguera-Julian M; IrsiCaixa AIDS Research Institute, Badalona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.
  • Godornes C; Department of Medicine and Department of Global Health, University of Washington, Seattle, WA, USA.
  • Casadellà M; IrsiCaixa AIDS Research Institute, Badalona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.
  • González-Beiras C; Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain.
  • Parera M; IrsiCaixa AIDS Research Institute, Badalona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Kapa Jnr A; Lihir Medical Center, International SOS-Newcrest Mining, Lihir Island, Papua New Guinea.
  • Houinei W; Disease Control Branch, National Department of Health, Port Moresby, Papua New Guinea.
  • Wangi J; Office of the WHO Representative for Papua New Guinea, WHO, Port Moresby, Papua New Guinea.
  • Corbacho-Monne M; Lihir Medical Center, International SOS-Newcrest Mining, Lihir Island, Papua New Guinea.
  • Paredes R; IrsiCaixa AIDS Research Institute, Badalona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Universitat de Vic-Universitat Central de Catalunya, Vic, Spain; Fundació Lluita contra la Sida, Infectious Diseases Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Gonzalez-Candelas F; Joint Research Unit for Infection and Public Health, FISABIO-University of Valencia, Institute for Integrative Systems Biology (I2SysBio), Valencia, Spain; CIBER in Epidemiology and Public Health, Valencia, Spain.
  • Marks M; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Hospital for Tropical Diseases, London, UK.
  • Lukehart SA; Department of Medicine and Department of Global Health, University of Washington, Seattle, WA, USA.
  • Thomson NR; Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK; Department of Infectious and Tropical Diseases, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Mitjà O; Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Lihir Medical Center, International SOS-Newcrest Mining, Lihir Island, Papua New Guinea; Fundació Lluita contra la Sida, Infectious Diseases Service, Hospital Universitari Germans Trias i Pujol, Badalon
Lancet Microbe ; 1(6): e263-e271, 2020 Oct.
Article en En | MEDLINE | ID: mdl-35544222
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Screening_studies Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Screening_studies Idioma: En Año: 2020 Tipo del documento: Article